Romidepsin is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Romidepsin becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about SaveRxCanada.to
List of countries where we can ship Romidepsin:
Latest news releases on Romidepsin:
Romidepsin, also known as Istodax, is an anticancer agent used in cutaneous T-cell lymphoma (CTCL) and other peripheral T-cell lymphomas (PTCLs). Romidepsin is a ...
A second-line systemic therapy for peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Includes full prescribing information, indications, preparation, dosing ...
Istodax official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.
Romidepsin (Istodax) chemotherapy side effects, how it's given, how it works, precautions and self care tips for treatment of t-cell lymphoma
Easy to read patient leaflet for romidepsin. Includes indications, proper use, special instructions, precautions, and possible side effects.
The recommended dose of romidepsin is 14mg/m2 administered intravenously over a 4-hour period on days 1, 8, and 15 of a 28-day cycle. Cycles should be repeated
Romidepsin (Istodax ®), a selective inhibitor of histone deacetylases (HDACs), was approved for the treatment of cutaneous T-cell lymphoma in November 2009 by the U ...
Information from the FDA about the approval of this drug and the clinical trials that led to the approval.
This page contains brief information about romidepsin and a collection of links to more information about the use of this drug, research results, and ongoing clinical ...
For US caregivers: A second-line systemic therapy for peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Includes full prescribing information, indications ...